FILE PHOTO: The logo of Teva Pharmaceutical Industries during a news conference held by its CEO, Kare Schultz, to discuss the company’s 2019 outlook in Tel Aviv, Israel February 19, 2019. REUTERS/Amir Cohen/File Photo